Last reviewed · How we verify

Fenugreek seed meal

Tel-Aviv Sourasky Medical Center · Phase 1 active Small molecule

Fenugreek seed meal is a Small molecule drug developed by Tel-Aviv Sourasky Medical Center. It is currently in Phase 1 development.

At a glance

Generic nameFenugreek seed meal
SponsorTel-Aviv Sourasky Medical Center
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fenugreek seed meal

What is Fenugreek seed meal?

Fenugreek seed meal is a Small molecule drug developed by Tel-Aviv Sourasky Medical Center.

Who makes Fenugreek seed meal?

Fenugreek seed meal is developed by Tel-Aviv Sourasky Medical Center (see full Tel-Aviv Sourasky Medical Center pipeline at /company/tel-aviv-sourasky-medical-center).

What development phase is Fenugreek seed meal in?

Fenugreek seed meal is in Phase 1.

Related